Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19
Dusan Hanidziar, Simon C. Robson
AJP Lung Cellular and Molecular Physiology (2020) Vol. 320, Iss. 1, pp. L12-L16
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
Lixue Huang, Qun Yao, Xiaoying Gu, et al.
The Lancet (2021) Vol. 398, Iss. 10302, pp. 747-758
Open Access | Times Cited: 976
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study
Xiaojun Wu, Xiaofan Liu, Yilu Zhou, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 7, pp. 747-754
Open Access | Times Cited: 621
Post-COVID syndrome. A case series and comprehensive review
Juan‐Manuel Anaya, Manuel Rojas, Martha L. Salinas, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 11, pp. 102947-102947
Open Access | Times Cited: 201
The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm
Michał Zimecki, Jeffrey K. Actor, Marian L. Kruzel
International Immunopharmacology (2021) Vol. 95, pp. 107571-107571
Open Access | Times Cited: 54
Is post-COVID syndrome an autoimmune disease?
Juan‐Manuel Anaya, María Herrán, Santiago Beltrán, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 7, pp. 653-666
Closed Access | Times Cited: 32
COVID-19: A Redox Disease—What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment
Andrew F. Cumpstey, Anna D. Clark, Jérôme Santolini, et al.
Antioxidants and Redox Signaling (2021) Vol. 35, Iss. 14, pp. 1226-1268
Open Access | Times Cited: 39
Heart–lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement
Michael Dandel
Heart Failure Reviews (2021) Vol. 27, Iss. 4, pp. 1325-1339
Open Access | Times Cited: 34
O risco da hiperóxia em pacientes com COVID-19
Milena Brandão Rios, Sofia de Andrade Pereira, Talyta Borges Cordeiro, et al.
Brazilian Journal of Development (2022) Vol. 8, Iss. 12, pp. 77785-77806
Open Access | Times Cited: 23
SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets
Pooja Shivshankar, Harry Karmouty‐Quintana, Tingting Mills, et al.
Inflammation (2022) Vol. 45, Iss. 4, pp. 1430-1449
Open Access | Times Cited: 22
Knowledge, attitude, and practice of health professionals for oxygen therapy working in South Gondar zone hospitals, 2021: multicenter cross-sectional study
Basazinew Chekol Demilew, Agegnehu Mekonen, Agazhe Aemro, et al.
BMC Health Services Research (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 19
A prospective study on the administration and titration of oxygen therapy in mechanically ventilated patients
Saurabh Chandrakar, Ankit Agarwal, Gaurav Jain, et al.
Journal of Anaesthesiology Clinical Pharmacology (2025)
Open Access
Ferroptosis and hyperoxic lung injury: insights into pathophysiology and treatment approaches
Xiaoqiong Zhou, Lei Tian, Zongde Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The Role of Cuproptosis in Hyperoxia-Induced Lung Injury and Its Potential for Treatment
Kaihua Yu, Yunfei Gu, Ying Yao, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 4651-4664
Open Access
Nicotinamide mononucleotide mitigates hyperoxia-aggravated septic lung injury via the GPx4-mediated anti-ferroptosis signaling pathway in alveolar epithelial cells
Ning Zhao, Wenqiang Tao, Xiufang Ouyang, et al.
Free Radical Biology and Medicine (2025) Vol. 234, pp. 86-99
Closed Access
Alterations in Respiratory Function Test Three Months after Hospitalisation for COVID-19 Pneumonia: Value of Determining Nitric Oxide Diffusion
Marta Núñez Fernández, Cristina Ramos‐Hernández, Francisco García‐Río, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 10, pp. 2119-2119
Open Access | Times Cited: 26
Post-COVID Syndrome. A Case Series and Comprehensive Review
Juan‐Manuel Anaya, Manuel Rojas, Martha L. Salinas, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 25
Targeting CXCR1 alleviates hyperoxia-induced lung injury through promoting glutamine metabolism
Qin Hao, Wei Zhuang, Xiucheng Liu, et al.
Cell Reports (2023) Vol. 42, Iss. 7, pp. 112745-112745
Open Access | Times Cited: 7
Dual effects of supplemental oxygen on pulmonary infection, inflammatory lung injury, and neuromodulation in aging and COVID-19
Mosi Lin, Maleka T. Stewart, Sidorela Zefi, et al.
Free Radical Biology and Medicine (2022) Vol. 190, pp. 247-263
Open Access | Times Cited: 12
Lung function at three months after hospitalization due to COVID‑19 pneumonia: Comparison of alpha, delta and omicron variant predominance periods
Vasiliki Georgakopoulou, Sotiria Makrodimitri, Aikaterini Gkoufa, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 2
Open Access | Times Cited: 2
Respiratory Outcomes in Patients Following COVID-19-Related Hospitalization: A Meta-Analysis
Tao Guo, Fangfang Jiang, Yufei Liu, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 15
Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm
Abdullahi Rabiu Abubakar, Rahnuma Ahmad, Adekunle Babajide Rowaiye, et al.
Life (2022) Vol. 12, Iss. 4, pp. 478-478
Open Access | Times Cited: 11
Effect of low-to-moderate hyperoxia on lung injury in preclinical animal models: a systematic review and meta-analysis
Samuel Minkove, Rhea Dhamapurkar, Xizhong Cui, et al.
Intensive Care Medicine Experimental (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 6
Adenosine A2AR in viral immune evasion and therapy: unveiling new avenues for treating COVID-19 and AIDS
Muhammad Atif, Abdullah Alsrhani, Farrah Naz, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Nitrated fatty acid, 10-nitrooleate protects against hyperoxia-induced acute lung injury in mice
Venkata Ramireddy Narala, Lokesh V. Thimmana, Kalpana Panati, et al.
International Immunopharmacology (2022) Vol. 109, pp. 108838-108838
Closed Access | Times Cited: 7
Persistence of Diffusion Capacity Impairment and Its Relationship with Dyspnea 12 Months after Hospitalization for COVID-19
Alice J. Kang, Binaya Regmi, Christian Cornélissen, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1234-1234
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top